Recent in vivo studies have noted that PAI-1 inhibitors suppress tumor growth, angiogenesis, and metastasis of some cancers (e.g., ovarian cancer, lung carcinoma, urothelial carcinoma, and fibrosarcoma) [33–36]. The gene discussed is SERPINE1; the disease is ovarian carcinoma.